Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel

Takeshi Kikuchi, Satoshi Kubota, Koji Asaumi, Harumi Kawaki, Takashi Nishida, Kazumi Kawata, Shigeru Mitani, Yasuhiko Tabata, Toshihumi Ozaki, Masaharu Takigawa

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a unique molecule that promotes the entire endochondral ossification process and regeneration of damaged articular cartilage. Also, CCN2 has been shown to enhance the adhesion and migration of bone marrow stromal cells as well as the growth and differentiation of osteoblasts; hence, its utility in bone regeneration has been suggested. Here, we evaluated the effect of CCN2 on the regeneration of an intractable bone defect in a rat model. First, we prepared two recombinant CCN2s of different origins, and the one showing the stronger effect on osteoblasts in vitro was selected for further evaluation, based on the result of an in vitro bioassay. Next, to obtain a sustained effect, the recombinant CCN2 was incorporated into gelatin hydrogel that enabled the gradual release of the factor. Evaluation in vivo indicated that CCN2 continued to be released at least for up to 14 days after its incorporation. Application of the gelatin hydrogel-CCN2 complex, together with a collagen scaffold to the bone defect prepared in a rat femur resulted in remarkable induction of osteoblastic mineralization markers within 2 weeks. Finally, distinct enhancement of bone regeneration was observed 3 weeks after the application of the complex. These results confirm the utility of CCN2 in the regeneration of intractable bone defects in vivo when the factor is incorporated into gelatin hydrogel.

Original languageEnglish
Pages (from-to)1089-1098
Number of pages10
JournalTissue Engineering - Part A
Volume14
Issue number6
DOIs
Publication statusPublished - Jun 1 2008

Fingerprint

Bone Regeneration
Hydrogel
Gelatin
Hydrogels
Bone
Osteoblasts
CCN Intercellular Signaling Proteins
Connective Tissue Growth Factor
Defects
Rats
Articular Cartilage
Mesenchymal Stromal Cells
Osteogenesis
Biological Assay
Femur
Regeneration
Collagen
Bioassay
Cartilage
Scaffolds (biology)

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomedical Engineering
  • Biomaterials

Cite this

Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel. / Kikuchi, Takeshi; Kubota, Satoshi; Asaumi, Koji; Kawaki, Harumi; Nishida, Takashi; Kawata, Kazumi; Mitani, Shigeru; Tabata, Yasuhiko; Ozaki, Toshihumi; Takigawa, Masaharu.

In: Tissue Engineering - Part A, Vol. 14, No. 6, 01.06.2008, p. 1089-1098.

Research output: Contribution to journalArticle

Kikuchi, Takeshi ; Kubota, Satoshi ; Asaumi, Koji ; Kawaki, Harumi ; Nishida, Takashi ; Kawata, Kazumi ; Mitani, Shigeru ; Tabata, Yasuhiko ; Ozaki, Toshihumi ; Takigawa, Masaharu. / Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel. In: Tissue Engineering - Part A. 2008 ; Vol. 14, No. 6. pp. 1089-1098.
@article{be786f210e644c4c88fc7d324355f3c9,
title = "Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel",
abstract = "CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a unique molecule that promotes the entire endochondral ossification process and regeneration of damaged articular cartilage. Also, CCN2 has been shown to enhance the adhesion and migration of bone marrow stromal cells as well as the growth and differentiation of osteoblasts; hence, its utility in bone regeneration has been suggested. Here, we evaluated the effect of CCN2 on the regeneration of an intractable bone defect in a rat model. First, we prepared two recombinant CCN2s of different origins, and the one showing the stronger effect on osteoblasts in vitro was selected for further evaluation, based on the result of an in vitro bioassay. Next, to obtain a sustained effect, the recombinant CCN2 was incorporated into gelatin hydrogel that enabled the gradual release of the factor. Evaluation in vivo indicated that CCN2 continued to be released at least for up to 14 days after its incorporation. Application of the gelatin hydrogel-CCN2 complex, together with a collagen scaffold to the bone defect prepared in a rat femur resulted in remarkable induction of osteoblastic mineralization markers within 2 weeks. Finally, distinct enhancement of bone regeneration was observed 3 weeks after the application of the complex. These results confirm the utility of CCN2 in the regeneration of intractable bone defects in vivo when the factor is incorporated into gelatin hydrogel.",
author = "Takeshi Kikuchi and Satoshi Kubota and Koji Asaumi and Harumi Kawaki and Takashi Nishida and Kazumi Kawata and Shigeru Mitani and Yasuhiko Tabata and Toshihumi Ozaki and Masaharu Takigawa",
year = "2008",
month = "6",
day = "1",
doi = "10.1089/ten.tea.2007.0167",
language = "English",
volume = "14",
pages = "1089--1098",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Promotion of bone regeneration by CCN2 incorporated into gelatin hydrogel

AU - Kikuchi, Takeshi

AU - Kubota, Satoshi

AU - Asaumi, Koji

AU - Kawaki, Harumi

AU - Nishida, Takashi

AU - Kawata, Kazumi

AU - Mitani, Shigeru

AU - Tabata, Yasuhiko

AU - Ozaki, Toshihumi

AU - Takigawa, Masaharu

PY - 2008/6/1

Y1 - 2008/6/1

N2 - CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a unique molecule that promotes the entire endochondral ossification process and regeneration of damaged articular cartilage. Also, CCN2 has been shown to enhance the adhesion and migration of bone marrow stromal cells as well as the growth and differentiation of osteoblasts; hence, its utility in bone regeneration has been suggested. Here, we evaluated the effect of CCN2 on the regeneration of an intractable bone defect in a rat model. First, we prepared two recombinant CCN2s of different origins, and the one showing the stronger effect on osteoblasts in vitro was selected for further evaluation, based on the result of an in vitro bioassay. Next, to obtain a sustained effect, the recombinant CCN2 was incorporated into gelatin hydrogel that enabled the gradual release of the factor. Evaluation in vivo indicated that CCN2 continued to be released at least for up to 14 days after its incorporation. Application of the gelatin hydrogel-CCN2 complex, together with a collagen scaffold to the bone defect prepared in a rat femur resulted in remarkable induction of osteoblastic mineralization markers within 2 weeks. Finally, distinct enhancement of bone regeneration was observed 3 weeks after the application of the complex. These results confirm the utility of CCN2 in the regeneration of intractable bone defects in vivo when the factor is incorporated into gelatin hydrogel.

AB - CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a unique molecule that promotes the entire endochondral ossification process and regeneration of damaged articular cartilage. Also, CCN2 has been shown to enhance the adhesion and migration of bone marrow stromal cells as well as the growth and differentiation of osteoblasts; hence, its utility in bone regeneration has been suggested. Here, we evaluated the effect of CCN2 on the regeneration of an intractable bone defect in a rat model. First, we prepared two recombinant CCN2s of different origins, and the one showing the stronger effect on osteoblasts in vitro was selected for further evaluation, based on the result of an in vitro bioassay. Next, to obtain a sustained effect, the recombinant CCN2 was incorporated into gelatin hydrogel that enabled the gradual release of the factor. Evaluation in vivo indicated that CCN2 continued to be released at least for up to 14 days after its incorporation. Application of the gelatin hydrogel-CCN2 complex, together with a collagen scaffold to the bone defect prepared in a rat femur resulted in remarkable induction of osteoblastic mineralization markers within 2 weeks. Finally, distinct enhancement of bone regeneration was observed 3 weeks after the application of the complex. These results confirm the utility of CCN2 in the regeneration of intractable bone defects in vivo when the factor is incorporated into gelatin hydrogel.

UR - http://www.scopus.com/inward/record.url?scp=45549107295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549107295&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2007.0167

DO - 10.1089/ten.tea.2007.0167

M3 - Article

C2 - 19230129

AN - SCOPUS:45549107295

VL - 14

SP - 1089

EP - 1098

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 6

ER -